Momenta Pharmaceuticals Inc. | Date: 2015-09-09
The present invention provides methods of evaluating a glycoprotein preparation for the absence, presence or amount of an N-acetylhexosamine glycan, e.g., an N-acetylglucosamine glycan.
Momenta Pharmaceuticals Inc. | Date: 2015-10-14
The invention provides methods, databases and systems for making glycoprotein products having defined properties.
Momenta Pharmaceuticals Inc. | Date: 2015-08-21
Momenta Pharmaceuticals Inc. | Date: 2015-11-13
Methods for analyzing, selecting, characterizing or classifying compositions of a co-polymer, e.g., glatiramer acetate are described. The methods entail analysis of pyro-glutamate in the composition, and, in some methods, comparing the amount of pyro-glutamate present in a composition to a reference standard.
Momenta Pharmaceuticals Inc. | Date: 2015-03-25
The present disclosure relates to methods of evaluating, identifying, and/or producing (e.g., manufacturing) pharmaceutical products (e.g., protein therapeutics). In some instances, methods herein allow highly resolved evaluation of the disulfide bond profiles of protein therapeutics.